Current HIV Research

Volume 23, Issue 6

Editorial

Current HIV Research Thematic Issue on “HIV Vaccine Development”

Pp: 351-352
Author(s): John P. Moore*
DOI: 10.2174/011570162X450381251027072501

Cite

Perspective

Fc Functions and Anti-HIV Neutralizing Antibodies: A Perspective

Pp: 353-356
Author(s): Hillary A. Vanderven and Stephen J. Kent*
DOI: 10.2174/011570162X353682250314070148

Cite

Mini-Review Article

The RV144 Trial Might Still Yield Useful Information

Pp: 357-362
Author(s): John P. Moore*
DOI: 10.2174/011570162X355671250402083527

Cite

Review Article

Characterization of Early Viral Populations in Infants Acquiring HIV Through Perinatal and Breastmilk Transmission: A Review of what is Currently Known and the Gaps that Need to be Addressed to Guide Passive HIV Immunization of Breastfeeding Infants

Pp: 363-379
Author(s): Elena E. Giorgi*, Melissa-Rose Abrahams, Genevieve Fouda, Grace John-Stewart, Ameena Goga, James I. Mullins, Sallie R. Permar, Holly E. Janes and Troy M. Martin
DOI: 10.2174/011570162X357975250902104402

Cite

Review Article

The Germline Targeting Vaccine Concept: Overview and Updates from HIV Pre-Clinical and Clinical Trials

Pp: 380-390
Author(s): Leonidas Stamatatos*
DOI: 10.2174/011570162X358302250206074255

Cite

Review Article

Funding Strategies to Foster Enabling Basic Science Research in the Development of an HIV Vaccine

Pp: 391-399
Author(s): Stuart Z. Shapiro*
DOI: 10.2174/011570162X360804250527065110

Cite

Review Article

Innovative Single-Cell Sequencing Techniques for B cell Analysis and Their Implications for Rational HIV-1 Vaccine Design

Pp: 400-413
Author(s): Denise Guerra, Laura T.M. Graus, Tim Beaumont, Mathieu Claireaux and Marit J. van Gils*
DOI: 10.2174/011570162X362655250620115404

Cite

Review Article

HIV-1 bNAb Vaccinal Effect – An Underachieving Goal?

Pp: 414-427
Author(s): Hannah King, Mario Roederer and Diane L. Bolton*
DOI: 10.2174/011570162X362665250727012610

Cite

Review Article

Current Approaches for Assessments of Neutralizing, Binding, and Effector Functions of Antibodies on the Path to Antibody-Mediated Prevention Strategies for HIV-1

Pp: 428-441
Author(s): David C. Montefiori*, Guido Ferrari, Dieter Mielke, LaTonya D. Williams and Georgia D. Tomaras
DOI: 10.2174/011570162X363301250314034023

Cite

Review Article

Accelerating Innovation: Advancing Opportunities in HIV Vaccine Development

Pp: 442-455
Author(s): Carlos A. Diazgranados, Thandi Onami and Pervin Anklesaria*
DOI: 10.2174/011570162X364991250710044947

Cite

Review Article

Germline-Targeting Strategies to Induce bNAbs against HIV-1

Pp: 456-481
Author(s): Tugba Atabey, Rogier W Sanders and Yoann Aldon*
DOI: 10.2174/011570162X365229250527111140

Cite

Review Article

Africa is an Essential Partner in the Research and Development of an HIV Vaccine

Pp: 482-493
Author(s): Glenda Gray*, Carolyn Williamson, Linda-Gail Bekker, Brodie Daniels, Werner Smidt, Nigel Garrett, Cissy Kityo Mutuluuza, Betty Mwesigwa, Lynda Stranix-Chibanda, Alash'le Akimbu, Andrew Obuku, Tian Johnson, Prossy Naluyima, Fredrick Sawe, Wendy Burgers, Nyanda Ntiginya, Neetha Morar, Azwidihwi Takalani, Simone Hendricks, Kubashni Woeber, Fatima Abrahams, Martha Tholanah, Stephen Mugamba, Michelle Mulder and Penny Moore
DOI: 10.2174/011570162X361496250627004203

Cite

Review Article

Unveiling an Immunological Mystery: Deciphering the Durability Divide in Vaccine-Elicited Antibody Responses

Pp: 494-509
Author(s): George K. Lewis*, Stanca Ciupe and Mohammad Sajadi
DOI: 10.2174/011570162X366336250707084941

Cite

Review Article

Integration of Preclinical and Clinical Vaccine Safety and Immunogenicity Testing for Development of a Pediatric HIV Vaccine to Achieve Protective HIV Immunity Prior to Adolescence

Pp: 510-524
Author(s): Genevieve G. Fouda*, Anjali Singh, Ashley Nelson, Holly Janes, Troy Martin, Ofer Levy, Di Wu, Fei Zou, Patrick Jean-Philippe, Kristina De Paris, Koen K.A. Van Rompay and Sallie R. Permar
DOI: 10.2174/011570162X366522250721113420